Polymorphism of the IL-8 gene and the risk of ovarian cancer

Cytokine

Volumn 71, Issue 2, 2015, Pages 334-338

  Koensgen, D ^a   Bruennert, D ^a   Ungureanu, S ^a,b   Sofroni, D ^b   Braicu, E I ^c   Sehouli, J ^c   Sumnig A ^d   Delogu, S ^a   Zygmunt, M ^a   Goyal, P ^a,g   Evert, M ^a   Olek, S ^e   Biebler, K E ^f   Mustea, A ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b Institute of Oncology   (Moldova)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Institute for Immunology and Transfusion Medicine   (Germany)

^e EPIONTIS GMBH   (Germany)

^f Institute of Biometrics and Medical Informatics   (Germany)

^g CENTRAL UNIVERSITY OF RAJASTHAN   (India)

Author keywords

IL 8 polymorphism; Ovarian cancer; PCR

Indexed keywords

GENOMIC DNA; INTERLEUKIN 8; CYTOKINE; IL8 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENOTYPE; HIGH RISK POPULATION; HUMAN; INTERLEUKIN 8 GENE; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; OVARY CANCER; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CASE CONTROL STUDY; CLINICAL TRIAL; EUROPE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MULTICENTER STUDY; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE SEQUENCE; OVARY TUMOR; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; CYTOKINES; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-8; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84921269090     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.07.254     Document Type: Article

References (35)

1. Sehouli J., Alvarez A.M., Manouchehrpour S., Ghatage P., Szczylik C., Zimmermann A., et al. A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer. Gynecol Oncol 2012, 124(2):205-209.
2. Sehouli J., Savvatis K., Braicu E.I., Schmidt S.C., Lichtenegger W., Fotopoulou C. Primary vs. interval debulking surgery in advanced ovarian cancer: results from a systematic single-center analysis. Int J Gynecol Cancer 2010, 20(8):1331-1340.
3. Kassim S.K., El-Salahy E.M., Fayed S.T., Helal S.A., Helal T., Azzam Eel D., et al. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem 2004, 37:363-369.
4. Mayerhofer K., Bodner K., Bodner-Adler B., Schindl M., Kaider A., Hefler L., et al. Interleukin-8 serum level shift in patients with ovarian carcinoma undergoing paclitaxel-containing chemotherapy. Cancer 2001, 91:388-393.
5. Xie J.J., Wang J., Tang T.T., Chen J., Gao X.L., Yuan J., et al. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2010, 49(2):185-193.
6. Rafrafi A., Chahed B., Kaabachi S., Kaabachi W., Maalmi H., Hamzaoui K., et al. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: a case control study. Hum Immunol 2013, 74(10):1368-1374.
7. Mukaida N., Shiroo M., Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989, 143(4):1366-1371.
8. Harada A., Sekido N., Akahoshi T., Wada T., Mukaida N., Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukocyte Biol 1994, 56(5):559-564.
9. Araki S., Omori Y., Lyn D., Singh R.K., Meinbach D.M., Sandman Y., et al. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Cancer Res 2007, 67:6854-6860.
10. Gabellini C., Trisciuoglio D., Desideri M., Candiloro A., Ragazzoni Y., Orlandi A., et al. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur J Cancer 2009, 45:2618-2627.
11. Lokshin A.E., Winans M., Landsittel D., Marrangoni A.M., Velikokhatnaya L., Modugno F., et al. Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecol Oncol 2006, 102(2):244-251.
12. Wang Y., Xu R.C., Zhang X.L., Niu X.L., Qu Y., Li L.Z., et al. Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion. Cytokine 2012, 59:145-155.
13. Sehouli J., Könsgen D., Mustea A., Oskay-Ozcelik G., Katsares I., Weidemann H., et al. IMO - intraoperative mapping of ovarian cancer. Zentralbl Gynakol 2003, 125(3-4):129-135.
14. Hacking D., Knight J.C., Rockett K., Brown H., Frampton J., Kwiatkowski D.P., et al. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun 2004, 5:274-282.
15. Liu C.M., Yeh C.J., Yu C.C., Chou M.Y., Lin C.H., Wei L.H., et al. Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. Oral Dis 2012, 18(3):307-314.
16. Song B., Zhang D., Wang S., Zheng H., Wang X. Association of interleukin-8 with cachexia from patients with low-third gastric cancer. Comp Funct Genomics 2009, 10.1155/2009/212345.
17. Vogiatzi K., Apostolakis S., Voudris V., Thomopoulou S., Kochiadakis G.E., Spandidos D.A. Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention. J Thromb Thrombolysis 2010, 29(1):134-140.
18. Emonts M., Hazes M.J., Houwing-Duistermaat J.J., van der Gaast-de Jongh C.E., de Vogel L., Han H.K., et al. Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. BMC Med Genet 2011, 12:36.
19. Chien M.H., Yeh C.B., Li Y.C., Wei L.H., Chang J.H., Peng Y.T., et al. Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development. J Surg Oncol 2011, 104(7):798-803.
20. Wang J.L., Nong L.G., We Y.S., Tang Y.J., Wang J.C., Wang C.F. Association of interleukin-8 gene polymorphisms with the risk of hepatocellular carcinoma. Mol Biol Rep 2014, 41(1). [Epub ahead of print].
21. Heinzmann A., Ahlert I., Kurz T., Berner R., Deichmann K.A. Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2004, 114(3):671-676.
22. Hacking D., Knight J.C., Rockett K., Brown H., Frampton J., Kwiatkowski D.P., et al. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun 2004, 5(4):274-282.
23. Kamangar F., Abnet C.C., Hutchinson A.A., Newschaffer C.J., Helzlsouer K., Shugart Y.Y., et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 2006, 17:117-125.
24. Yu Y., Chadee K. The 3k-untranslated region of human interleukin-8 mRNA suppresses IL-8 gene expression. Immunology 2001, 102:498-505.
25. Suswam E.A., Nabors L.B., Huang Y., Yang X., King P.H. IL-1β induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3' untranslated region: involvement of divergent RNA-binding factors HuR, KSRP and TIAR. Int J Cancer 2005, 113:911-919.
26. Wagoner J., Austin M., Green J., Imaizumi T., Casola A., Brasier A., et al. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol 2007, 81(1):309-318.
27. Tabel Y., Mir S., Berdeli A. Interleukin 8 gene 2767 A/G polymorphism is associated with increased risk of nephritis in children with Henoch-Schönlein purpura. Rheumatol Int 2012, 32:941-947.
28. Artifoni L., Negrisolo S., Montini G., Zucchetta P., Molinari P.P., Cassar W., et al. Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J Urol 2007, 177:1102-1106.
29. Chen R.H., Chen W.C., Wang T.Y., Tsai C.H., Tsai F.J. Lack of association between pro-inflammatory cytokine (IL-6, IL-8 and TNF-α) gene polymorphisms and Graves' disease. Int J Immunogenet 2005, 32(6):343-347.
30. Hsieh Y.Y., Chang C.C., Tsai C.H., Lin C.C., Tsai F.J. Interleukin (IL)-12 receptor β1 codon 378 G homozygote and allele, but not IL-1 (β-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3=-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma. Fertil Steril 2007, 87(4):886-895.
31. Tsai Y.Y., Lin J.M., Wan L., Lin H.J., Tsai Y., Lee C.C., et al. Interleukin gene polymorphisms in age-related macular degeneration. Invest Ophthalmol Vis Sci 2008, 49(2):693-698.
32. Liu C.M., Yeh C.J., Yu C.C., Chou M.Y., Lin C.H., Wei L.H., et al. Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. Oral Dis 2012, 18:307-314.
33. Lo S.F., Huang C.M., Lin H.C., Chen W.C., Tsai C.H., Tsai F.J. Cytokine (IL-6) and chemokine (IL-8) gene polymorphisms among rheumatoid arthritis patients in Taiwan. Clin Exp Rheumatol 2008, 26(4):632-637.
34. Wang Y., Xu R.C., Zhang X.L., Niu X.L., Qu Y., Li L.Z., et al. Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion. Cytokine 2012, 59(1):145-155.
35. Browne A., Sriraksa R., Guney T., Rama N., Van Noorden S., Curry E., et al. Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours. Cytokine 2013, 64(1):413-421.